| Literature DB >> 12526021 |
Abstract
Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) plays a critical role in glucose and lipid metabolism. More recently, PPAR-gamma ligands have been reported to inhibit the expression of proinflammatory molecules by monocytes/macrophages. Of relevance to CNS disease is that PPAR-gamma agonists have been demonstrated to have similar effects on microglia. PPAR-gamma agonists also ameliorate experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. This Mini-Review summarizes the effects of PPAR-gamma agonists in mediating immune responses and the potential of these agonists in the treatment of inflammatory disorders of the CNS. Copyright 2002 Wiley-Liss, Inc.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12526021 DOI: 10.1002/jnr.10501
Source DB: PubMed Journal: J Neurosci Res ISSN: 0360-4012 Impact factor: 4.164